Salon: How a debate over two competing vaccines gripped the medical community — in 1961
Polio vaccine developed by UC's Albert Sabin embraced by world, then U.S. 60 years ago
When a polio epidemic swept across the globe for much of the 20th century, a pair of researchers raced to develop a vaccine to halt the disabling virus that could lead to paralysis.
Salon.com is out with an in-depth feature story about the efforts of Albert Sabin, a University of Cincinnati researcher, and Jonas Salk, a University of Pittsburgh scientist. Both are credited with incredible breakthroughs that ultimately led to eliminating the virus in most of the world. According to the Centers for Disease Control, no cases have originated in the United States since 1979.
Dr. Albert B. Sabin was a pre-eminent medical investigator from the University of Cincinnati and Cincinnati Children's Hospital who dedicated his life to researching the causes and cures of viruses and disease.
According to the Salon article, "the U.S. felt that Salk's vaccine had solved the polio problem and there was no need for another vaccine. So, Sabin turned to other countries for support.
"In the Soviet Union, millions of people participated in a clinical trial. With its success established, the Soviet Union began manufacturing Sabin's vaccine. It is remarkable that at the height of the Cold War an American polio vaccine got its first foothold in the communist world. Eventually, Sabin's vaccine would be approved for use in the United States in 1961 and, in a victory for Sabin, replaced Salk's vaccine in 1962."
Read the complete article
Featured image at top: Albert Sabin, MD, administers the live oral polio vaccine to children.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Follow all of UC's advanced related to the COVID-19 vaccine, or schedule a virtual visit to UC and begin picturing yourself at an institution that inspires incredible breakthroughs.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.